Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03278717
What this trial is testing

Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
University College, London 330
Large-scale testing (Phase 3)UnknownNCT01087268
What this trial is testing

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Who this might be right for
Bladder CancerCervical CancerColorectal Cancer+9 more
Royal Marsden NHS Foundation Trust 75
Testing effectiveness (Phase 2)Study completedNCT00193297
What this trial is testing

Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma

Who this might be right for
Ovary Cancer
SCRI Development Innovations, LLC 50
Early research (Phase 1)Study completedNCT01469793
What this trial is testing

DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Genentech, Inc. 71
Testing effectiveness (Phase 2)WithdrawnNCT06393751
What this trial is testing

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Who this might be right for
Platinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02054351
What this trial is testing

Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)

Who this might be right for
Ovarian Cancer
Ganymed Pharmaceuticals GmbH 42
Not applicableNot Yet RecruitingNCT06838429
What this trial is testing

PARPi and Ovarian Cancer Survival

Who this might be right for
Epithelial Ovarian Cancer, Fallopian Tube or PeritoneumPARP Inhibitor
Shanghai Gynecologic Oncology Group 6,000
Testing effectiveness (Phase 2)Looking for participantsNCT07042802
What this trial is testing

LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Nanjing Leads Biolabs Co.,Ltd 180
Testing effectiveness (Phase 2)Looking for participantsNCT03878849
What this trial is testing

Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

Who this might be right for
Advanced Ovarian Cancer
Allarity Therapeutics 40
Early research (Phase 1)Ended earlyNCT01312376
What this trial is testing

Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer

Who this might be right for
Ovarian CarcinomaFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 18
Early research (Phase 1)Ended earlyNCT01485874
What this trial is testing

Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hoosier Cancer Research Network 11
Not applicableStudy completedNCT03379376
What this trial is testing

EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery

Who this might be right for
Female Reproductive System NeoplasmMalignant Female Reproductive System NeoplasmMalignant Uterine Neoplasm+4 more
Wake Forest University Health Sciences 10
Not applicableActive Not RecruitingNCT02828618
What this trial is testing

Trial on Radical Upfront Surgery in Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
AGO Study Group 797
Testing effectiveness (Phase 2)Study completedNCT01905163
What this trial is testing

Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cavity Cancer
Centre Jean Perrin 47
Testing effectiveness (Phase 2)Study completedNCT03188432
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Stage IIIC Fallopian Tube CancerStage IIIC Ovarian CancerStage IIIC Primary Peritoneal Cancer+3 more
Wake Forest University Health Sciences 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07295132
What this trial is testing

RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)

Who this might be right for
Ovarian Cancer RecurrentPlatinum Sensitive Ovarian Cancer
Asan Medical Center 160
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT06517485
What this trial is testing

First-in-Human Dose Expansion Study of XMT-1536 in Cancers Likely to Express NaPi2b

Who this might be right for
Platinum Resistant Ovarian CancerNon-Small Cell Adenocarcinoma
Mersana Therapeutics 142
Early research (Phase 1)Active Not RecruitingNCT04024878
What this trial is testing

NeoVax With Nivolumab in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Dana-Farber Cancer Institute 22
Early research (Phase 1)Looking for participantsNCT07244835
What this trial is testing

DEG6498 in Participants With Solid Tumors

Who this might be right for
Malignant Neoplasms
Degron Therapeutics Co. 100
Next Page